rs3735035

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001018111.3(PODXL):​c.334G>A​(p.Gly112Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.451 in 1,613,396 control chromosomes in the GnomAD database, including 171,906 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.36 ( 12146 hom., cov: 30)
Exomes 𝑓: 0.46 ( 159760 hom. )

Consequence

PODXL
NM_001018111.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.61

Publications

36 publications found
Variant links:
Genes affected
PODXL (HGNC:9171): (podocalyxin like) This gene encodes a member of the sialomucin protein family. The encoded protein was originally identified as an important component of glomerular podocytes. Podocytes are highly differentiated epithelial cells with interdigitating foot processes covering the outer aspect of the glomerular basement membrane. Other biological activities of the encoded protein include: binding in a membrane protein complex with Na+/H+ exchanger regulatory factor to intracellular cytoskeletal elements, playing a role in hematopoetic cell differentiation, and being expressed in vascular endothelium cells and binding to L-selectin. [provided by RefSeq, Jul 2008]
PODXL Gene-Disease associations (from GenCC):
  • atypical juvenile parkinsonism
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • young-onset Parkinson disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.0459315E-5).
BP6
Variant 7-131511200-C-T is Benign according to our data. Variant chr7-131511200-C-T is described in ClinVar as Benign. ClinVar VariationId is 1222221.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.604 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PODXLNM_001018111.3 linkc.334G>A p.Gly112Ser missense_variant Exon 2 of 9 ENST00000378555.8 NP_001018121.1 O00592-1Q96N83
PODXLNM_005397.4 linkc.334G>A p.Gly112Ser missense_variant Exon 2 of 8 NP_005388.2 O00592-2Q96N83

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PODXLENST00000378555.8 linkc.334G>A p.Gly112Ser missense_variant Exon 2 of 9 1 NM_001018111.3 ENSP00000367817.3 O00592-1
PODXLENST00000322985.9 linkc.334G>A p.Gly112Ser missense_variant Exon 2 of 8 1 ENSP00000319782.9 O00592-2
PODXLENST00000446198.5 linkn.334G>A non_coding_transcript_exon_variant Exon 2 of 7 2 ENSP00000390152.1 G3V0E6
PODXLENST00000465001.1 linkn.525G>A non_coding_transcript_exon_variant Exon 3 of 3 4

Frequencies

GnomAD3 genomes
AF:
0.363
AC:
55002
AN:
151590
Hom.:
12130
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0955
Gnomad AMI
AF:
0.436
Gnomad AMR
AF:
0.379
Gnomad ASJ
AF:
0.388
Gnomad EAS
AF:
0.622
Gnomad SAS
AF:
0.376
Gnomad FIN
AF:
0.498
Gnomad MID
AF:
0.345
Gnomad NFE
AF:
0.478
Gnomad OTH
AF:
0.367
GnomAD2 exomes
AF:
0.436
AC:
109490
AN:
251408
AF XY:
0.436
show subpopulations
Gnomad AFR exome
AF:
0.0877
Gnomad AMR exome
AF:
0.428
Gnomad ASJ exome
AF:
0.402
Gnomad EAS exome
AF:
0.625
Gnomad FIN exome
AF:
0.506
Gnomad NFE exome
AF:
0.467
Gnomad OTH exome
AF:
0.436
GnomAD4 exome
AF:
0.461
AC:
673388
AN:
1461688
Hom.:
159760
Cov.:
58
AF XY:
0.459
AC XY:
333444
AN XY:
727152
show subpopulations
African (AFR)
AF:
0.0796
AC:
2665
AN:
33478
American (AMR)
AF:
0.425
AC:
18988
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.396
AC:
10344
AN:
26134
East Asian (EAS)
AF:
0.591
AC:
23481
AN:
39700
South Asian (SAS)
AF:
0.356
AC:
30680
AN:
86258
European-Finnish (FIN)
AF:
0.500
AC:
26732
AN:
53414
Middle Eastern (MID)
AF:
0.321
AC:
1854
AN:
5768
European-Non Finnish (NFE)
AF:
0.478
AC:
531842
AN:
1111828
Other (OTH)
AF:
0.444
AC:
26802
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
21774
43549
65323
87098
108872
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15612
31224
46836
62448
78060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.363
AC:
55032
AN:
151708
Hom.:
12146
Cov.:
30
AF XY:
0.365
AC XY:
27093
AN XY:
74126
show subpopulations
African (AFR)
AF:
0.0953
AC:
3945
AN:
41398
American (AMR)
AF:
0.380
AC:
5784
AN:
15232
Ashkenazi Jewish (ASJ)
AF:
0.388
AC:
1346
AN:
3468
East Asian (EAS)
AF:
0.622
AC:
3200
AN:
5146
South Asian (SAS)
AF:
0.376
AC:
1794
AN:
4768
European-Finnish (FIN)
AF:
0.498
AC:
5235
AN:
10520
Middle Eastern (MID)
AF:
0.354
AC:
104
AN:
294
European-Non Finnish (NFE)
AF:
0.478
AC:
32441
AN:
67876
Other (OTH)
AF:
0.375
AC:
787
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1574
3148
4722
6296
7870
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
536
1072
1608
2144
2680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.431
Hom.:
49013
Bravo
AF:
0.344
TwinsUK
AF:
0.481
AC:
1783
ALSPAC
AF:
0.470
AC:
1812
ESP6500AA
AF:
0.107
AC:
470
ESP6500EA
AF:
0.473
AC:
4070
ExAC
AF:
0.427
AC:
51851
Asia WGS
AF:
0.505
AC:
1753
AN:
3476
EpiCase
AF:
0.457
EpiControl
AF:
0.445

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.81
T
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.012
DANN
Benign
0.48
DEOGEN2
Benign
0.057
T;.
Eigen
Benign
-2.1
Eigen_PC
Benign
-2.2
FATHMM_MKL
Benign
0.017
N
LIST_S2
Benign
0.34
T;T
MetaRNN
Benign
0.000010
T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.34
N;N
PhyloP100
-1.6
PrimateAI
Benign
0.22
T
PROVEAN
Benign
1.2
N;N
REVEL
Benign
0.042
Sift
Benign
0.38
T;T
Sift4G
Benign
0.76
T;T
Polyphen
0.017
B;B
Vest4
0.053
MPC
0.24
ClinPred
0.0048
T
GERP RS
-5.6
Varity_R
0.065
gMVP
0.11
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3735035; hg19: chr7-131195959; COSMIC: COSV59870570; COSMIC: COSV59870570; API